Neumora Therapeutics, Inc.

NMRA·NASDAQ·$1.84Share Price as of 11/2·$341MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/30/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/06/25

Disclosures

8-KCurrent report10/30/26 8-KCurrent report08/14/26 8-KCurrent report07/27/26 8-KCurrent report06/15/26 8-KCurrent report05/29/26

Prospectuses and Registrations

S-8Registration of securities for employees03/30/26 POS AMPost-effective amendment03/03/25 POSASRProspectus / registration03/03/25 S-8Registration of securities for employees03/03/25 S-3ASRAutomatic shelf registration10/01/24

Proxies

DEF 14ADefinitive proxy04/17/26 DEFA14AAdditional proxy materials04/17/26 DEFA14AAdditional proxy materials05/16/25 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25

Ownership

144Proposed sale of securities08/21/26 Form 4Insider transaction08/21/26 Form 4Insider transaction08/21/26 Form 4Insider transaction08/21/26 Form 4Insider transaction08/21/26

Other

EFFECTRequest for effectiveness03/26/25 CERTCEO/CFO certification09/14/23 EFFECTRequest for effectiveness09/14/23 SEC STAFF LETTERSEC staff letter09/14/23 8-A12B8-A12B09/13/23